Welcome to GRACE






    Home

    Overview

    Confidentiality

    Bibliography

    Advisors

    Resources

    GRACE Map

    GRACE2 Map

    Members Room



    
   

GRACE Bibliography


Easily printable version (requires Adobe Acrobat)
GRACE Appendix (requires Adobe Acrobat)
Manuscripts
Non-GRACE publications
Abstracts

Abstracts

  1. Agnelli G, López-Sendón J, Dabbous OH, Lopez de Sa E, Gore JM, Brieger D, Van de Werf F, Gurfinkel EP, Fox KAA, for the GRACE Investigators. Bleeding events with lytics and thienopyridines in patients with ST-segment elevation myocardial infarction. The Global Registry of Acute Coronary Events. J Thromb Haemost 2005; 3(1):P1017.
  2. Agnelli G, Moscucci M, Fox KAA, Cannon CP, Klein W, White K, López-Sendón J, Montalescot G, Goldberg RJ, for the GRACE Investigators. Preventing major bleeding in acute coronary syndromes (ACS): lessons learned from the Global Registry of Acute Coronary Events (GRACE). Thromb Haemost 2001;86(Suppl 1):OC210.
  3. Akbar Ali O, Gurfinkel EP, Gore JM, Fox KAA, Budaj A, Agnelli G, Anderson FA, Dedrick R, Brieger D, for the GRACE Investigators. Relationship between white cell count, blood sugar level and mortality in acute coronary syndromes. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2006; 47(4):261A.
  4. Ambrosio G, Dabbous OH, del Pinto M, Tritto I, Agnelli G, Kennelly BM, López-Sendón J, Anderson FA, for the GRACE Investigators. Chronic nitrate therapy is associated with different clinical presentation of acute coronary syndromes. A possible mechanism of cardiac preconditioning? The Global Registry of Acute Coronary Events. Eur Heart J 2005;26(Abstract Suppl.):49.
  5. Anderson FA, Dabbous OH, Goldberg RJ, Fox KAA, Eagle KA, Avezum Á, Gurfinkel EP, Gore JM, for the GRACE Investigators. Persistent failure to close the age and gender gap in the use of evidence-based therapies in acute coronary syndromes: temporal trends (1999-2003) in the Global Registry of Acute Coronary Events. Circulation 2004;110(17 Suppl III):III-798.
  6. Avezum Á, Knobel M, Goldberg RJ, Sadiq I, Saperia G, Smyth T, Paoloni R, Brieger D, Kuznetsova P, Gore JM, the GRACE Investigators. Incidence and prognosis of ventricular tachycardia and ventricular fibrillation after non-ST elevation acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2004;43(5 Suppl A):116A.
  7. Avezum Á, Piegas LS, Goldberg RJ, Brieger DB, Stiles MK, Huang W, Gore JM. Prognosis and Predictors of Ventricular Tachycardia and Ventricular Fibrillation with Acute Coronary Syndromes. The Global Registry of Acute Coronary Events. Heart Rhythm 2007;4(5):S80
  8. Bakhai A, Dabbous OH, Cohen DJ, Flather MD, Greenberg D, Anderson FA Jr, Gurfinkel EP, White K, Fox KAA, the GRACE Investigators. Interhospital transfers are costly, cause delays and do not address the imbalance of access to revascularization: the case for more angiographic facilities? Results from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2004;43(5 Suppl A):402A.
  9. Barringhaus K, Montalescot G, Steg PG, Van de Werf F, López-Sendón J, Anderson FA, Dedrick R, Gore JM, for the GRACE Investigators. Risk-adjusted in-hospital mortality is similar between patients undergoing coronary artery bypass grafting vs percutaneous coronary intervention for residual multi-vessel disease following primary percutaneous revascularization. J Am Coll Cardiol 2007:49(Suppl I):195A
  10. Barringhaus KG, McManus DD, Steg PG, Montalescot G, Van de Werf F, López-Sendón J, Dedrick R, Gore JM, for the GRACE Investigators. Staged PCI for Residual Multi-Vessel Disease Following Primary PCI Is Associated with Low Mortality. JACC 2009 (in press).
  11. Biasi Cavalcanti A, Avezum Á, Steg PG, Fox KAA, Van de Werf F, Montalescot G, Dabbous OH, Knobel E, for the GRACE Investigators. Hyperglycemia increases hospital mortality in patients with acute coronary syndromes. Results from the Global Registry of Acute Coronary Events. Circulation 2004;110(17 Suppl III):III-785.
  12. Botkin N, Spencer FA, Goldberg RJ, Furman M, Montalescot G, Brieger D, Malone S, Gore JM, for the GRACE Investigators. Increasing occurrence of multivessel intervention and multiple stent placement from 1999 to 2004. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2006;47(4):261A.
  13. Brieger D, Dabbous OH, Eagle KA, Budaj A, Avezum Á, Granger CB, Costa B, Steg PhG, for the GRACE Investigators. Deriving a safety index from the GRACE risk score. Eur Heart J 2005; 26(Abstract Suppl.):566.
  14. Brieger D, Eagle KA, Goodman SG, López-Sendón J, Steg PhG, Budaj A, White K, Montalescot G, on behalf of the GRACE Investigators. Atypical presentation of ACS independently predicts MI and increased in-hospital mortality: insights from the GRACE registry. Eur Heart J 2002;23(Abstr Suppl):105.
  15. Brieger D, Fox KAA, Kritharides L, Anderson FA, Johnson J, Sadiq I, Klein W, Avezum Á. Limited impact of treatment with statins on early outcomes in unselected patients with acute coronary syndromes. Insights from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2002; A39.
  16. Brieger D, Gore JM, Goldberg RJ, Spencer F, DiBenedetto D, Eagle KA, Steg PG, Allegrone J, Fox KAA, for the GRACE Investigators. Early use of low-molecular-weight or unfractionated heparin in patients with non-ST-segment elevation myocardial infarction and unstable angina. The Global Registry of Acute Coronary Events. J Thromb Haemost 2005;3(1):P1693.
  17. Brieger D, Nussbacher A, Knobel M, Allegrone J, Avezum Á. Predictors of in-hospital coronary artery bypass grafting across the spectrum of acute coronary syndromes: an analysis from the Global Registry of Acute Coronary Events. Eur Heart J 2003;24(Abstr Suppl):71.
  18. Brito V, Perez de la Hoz R, Sampó E, Duronto E, Dabbous OH, Gowda N, Gurfinkel EP, the GRACE Investigators. Therapeutic strategies and outcomes in patients with previous coronary artery bypass graft following a new acute coronary syndrome: insights from the GRACE experience. J Am Coll Cardiol 2004;43(5 Suppl A):274A.
  19. Budaj A, Brieger D, Steg PG, for the GRACE Investigators. Global patterns of use of thrombolytic, antithrombotic and antiplatelet therapy in patients with acute coronary events; insights from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2000;21(Abstr Suppl):177.
  20. Budaj A, Flasinska K, Goldberg RJ, Gore JM, Dabbous O, Spencer F, Kuznetsova P, Fox KAA. Magnitude of, and risk factors for, stroke in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Eur Heart J 2003;24(Abstr Suppl):354.
  21. Budaj A, Flasinska K, Gurfinkel EP, Gore JM, López-Sendón J, Brieger D, Kennelly BM, FitzGerald G, Fox KAA, for the GRACE Investigators. Stroke risk score in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Circulation 2007;116(Abstr Suppl):II_857.
  22. Budaj A, Van de Werf F, Lim HS, Goldberg RG, Montalescot G, Gore JM, Dedrick R, Brieger D. Young patients with acute coronary syndromes have different clinical characteristics and better outcomes than older patients. The Global Registry of Acute Coronary Events. Eur Heart J 2007;28(Abstr Suppl):559.
  23. Cannon CP, Brieger D, Van de Werf F, Avezum Á, Lankes W, Kennelly B, Agnelli G, Mazurek T, Kasper RS, Montalescot G. Safety of the combination of low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors: observations from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2001;22(Abstr Suppl):592.
  24. Chew D, Anderson FA, Avezum Á, Eagle KA, Gulba D, Gore JM, Dedrick R, Brieger D, for the GRACE Investigators. Impact of clinical guideline adherence on 6-month survival: nested case-control analysis from the Global Registry of Acute Coronary Events. Eur Heart J 2006;27(Abstract Suppl):304.
  25. Collet J-P, Agnelli G, Van de Werf F, Brieger D, Gurfinkel EP, López-Sendón J, Gowda N, Montalescot G, on behalf of the GRACE Investigators. Low-molecular-weight heparin alone and with IIb/IIIa inhibitors in patients with renal failure and non-ST-elevation acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2003;41(6 Suppl A):335A.
  26. Dauerman HL, Goldberg RJ, White K, Gurfinkel EP, Lopez de Sa E, López-Sendón J, Gore JM. Global use of revascularization for patients in cardiogenic shock: findings from the Global Registry of Acute Coronary Events (GRACE). Circulation 2001;104(17 Suppl II):II-465.
  27. Devlin G, Gore JM, Elliott J, Avezum Á, Eagle KA, Anderson FA, Huang W, Brieger D, for the GRACE Investigators. Improved outcomes after in-hospital revascularization in the elderly and very elderly with high-risk non-ST-elevation acute coronary syndromes. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2006;47(4):252A.
  28. Devlin G, Sadiq I, Heald S, Davidson M, López-Sendón J, Brieger D, Avezum Á, Elliott JM. Is low risk no risk? Management of low risk patients presenting with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2001;22(Abstr Suppl):525.
  29. Devlin G, Swanson N, Silverstone A, Montalescot G, Eagle KA, Goodman SG, Huang W, Brieger D. Do treatment delays influence outcomes following presentation with non-ST elevation acute coronary syndrome? The GRACE registry. Eur Heart J 2007;28(Abstr Suppl):65.
  30. Dey S, Fox KAA, Gurfinkel EP, Anderson Jr., FA, Gowda N, Brieger D, Eagle KA, for the GRACE Investigators. Apparent gender bias in the treatment of women with an acute coronary syndrome. The Global Registry of Acute Coronary Events. Eur Heart J 2005; 26(Abstract Suppl.):216.
  31. Dey S, Klein W, Flather MD, Devlin G, Brieger D, Gowda N, Eagle KA, for the GRACE Investigators. Coronary disease in women is different from that in men with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Circulation 2003;108(17 Suppl IV):IV-717.
  32. Duronto D, Gurfinkel EP, Eagle KA, Goldberg RJ, Brieger D, Freedman B, Jelinek M, Fitzgerald G, Gore JM. Distinguishing Features of Mild vs Severe Coronary Artery Disease in Patients With Acute Coronary Syndromes. The Global Registry of Acute Coronary Events. Circulation 2008.
  33. Eagle K, for the GRACE Investigators. Practice variation in reperfusion strategies for ST-segment elevation myocardial infarction – early findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2000;21(Abstr Suppl):527.
  34. Eagle K, Gore JM, Sullivan CM, Goldberg RJ, Granger C, Fox KAA, Sadiq I. Estimating the risk of adverse outcomes in the ‘average patient’ with acute coronary syndromes: comparing a risk model from a clinical trial to that developed in a similar cohort in the GRACE registry. Eur Heart J 2001;22(Abstr Suppl):524.
  35. Eagle KA, Lim MJ, Budaj A, Dabbous OH, Pieper K, Goodman SG, Granger CB, Steg PhG, Gore JM, Fox KAA, on behalf of the GRACE Investigators. A robust prediction model for all forms of acute coronary syndromes: estimating the risk of in-hospital death and myocardial infarction in the Global Registry of Acute Coronary Events Registry. J Am Coll Cardiol 2003;41(6 Suppl A):353A.
  36. Eagle KA, Mehta RH, Nallamothu BK, Granger CB, Steg PhG, Van de Werf F, López-Sendón J, Goodman SG, Allegrone J, Fox KAA, for The GRACE Investigators. Global reperfusion therapy in acute myocardial infarction - 1999 to 2004: we’re getting better, but we have a long way to go. The Global Registry of Acute Coronary Events. Circulation 2005;112(Suppl):II-794-II-795.
  37. Emery M, López-Sendón JL, Steg PG, Anderson FA, Dabbous O, Scheuble A, Eagle KE, for the GRACE Investigators. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarctions with and without heart failure. Insights from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2005; 45 (3 Suppl A):188A.
  38. Fox KA, Gore JM, Montalescot G, Mukherjee D, Gowda N, Steg PhG, for the GRACE Investigators. Impact of insulin treatment on patients with ST-segment elevation myocardial infarction. The Global Registry of Acute Coronary Events. Circulation 2003;108(17 Suppl IV):IV-746.
  39. Fox KAA, Anderson FA, Dabbous OH , Goodman SG, Gore JM. Time course of events following presentation with acute coronary syndrome: observations from 33,402 patients in the Global Registry of Acute Coronary Events. Eur Heart J 2005; 26(Abstract Suppl.):118.
  40. Fox KAA, Carruthers K, Dunbar DR, Graham C, De Raedt H, Buysschaert, Lambrechts D, Van de Werf F. Underestimated and Under-recognised: The Late Consequences of Acute Coronary Syndrome (GRACE UK-Belgian Study). Eur Heart J 2010 (in press).
  41. Fox KAA, Carruthers K, Motivala A, Avezum A, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA.. Has the frequency of bleeding improved over time for patients presenting with an acute coronary syndrome? The GRACE Registry. Eur Heart J 2008;29(Abstr Suppl), 326.
  42. Fox KAA, Dabbous OH, Steg PG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Brieger D, for the GRACE Investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? Findings of the multinational GRACE registry. Eur Heart J 2004;25(Abstr Suppl):2109.
  43. Fox KAA, for the GRACE Investigators. Management of high-risk unstable angina and non-ST elevation myocardial infarction: variations in practice. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2000;21(Abstr Suppl):246.
  44. Fox KAA, Goldberg RJ, Pieper K, Cannon CP, Van de Werf F, Goodman SG, Dabbous O, Granger CB, on behalf of the GRACE Investigators. Predictors of in-hospital mortality in the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23(Abstr Suppl):626.
  45. Fox KAA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer FA, Budaj A, Dabbous OH, Gore JM, on behalf of the GRACE Investigators. Influence of guidelines and results from major clinical trials on medical practice: findings from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2003;41(6 Suppl A):518A.
  46. Fox KAA, Steg PhG, Goldberg RJ, Gore JM, Granger CB, Avezum Á, Eagle KA, Fitzgerald G, Van De Werf F. Can we predict non-fatal cardiovascular events in acute coronary syndrome? The Global Registry of Acute Coronary Events. Eur Heart J 2007;28(Abstr Suppl):689.
  47. Froehlich JB, Mukherjee D, Avezum Á, Budaj A, Kline-Rogers EM, López-Sendón J, Johnson J, Eagle KA, Mehta RH. Quality of care for patients with peripheral vascular disease during acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2003;41(6 Suppl A):252A.
  48. Furman MI, Davidson MC, Anderson FA Jr, Budaj A, Goodman SG, Avezum Á, López-Sendón J, Klein W, Gore JM. Relationship between elevated leukocyte count and hospital clinical events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events. Circulation 2001;104(17 Suppl II):II-650.
  49. Goldberg R, Spencer F, Steg PhG, López-Sendón J, Kennelly B, Flather MD, Montalescot G, Gurfinkel EP, Kuznetsova P, Gore J, the GRACE Investigators. Trends in the use of effective cardiac medications in patients with acute myocardial infarction: the GRACE experience. J Am Coll Cardiol 2004;43(5 Suppl A):262A.
  50. Goldberg RJ, Spencer F, Gore JM, Sadiq I, Sullivan C, Fox KAA, Steg PhG, Eagle KA, Granger C, Avezum Á. Six month prognosis after hospital discharge in patients with acute coronary syndromes: the GRACE project. J Am Coll Cardiol 2001;37(2 Suppl A):315A.
  51. Goldberg RJ, Spencer FA, López-Sendón J, Van de Werf F, Montalescot G, Anderson FA, Malone S, Granger CB. International and time trends in the use and characteristics of patients with acute coronary syndromes treated with clopidogrel: the GRACE experience. Eur Heart J 2005: Eur Heart J 2005; 26(Abstract Suppl.):160.
  52. Goodman S, Johnson J, Sullivan C, Steg PhG, Eagle K, Fox KAA, López-Sendón J, Montalescot G, Budaj A, Kennelly B, Gore J, for the GRACE Investigators. What is an MI? Prospective analysis of the diagnostic and prognostic impact of adding troponins to the definition of myocardial infarction. J Am Coll Cardiol 2001;37(2 Suppl A):358A.
  53. Goodman SG, Granger CB, White K, Brieger D, Budaj A, Dabbous OH, Steg PhG, on behalf of the GRACE Investigators. Acute coronary syndrome patients with ST-segment depression have substantial mortality rates but undergo less aggressive management strategies: insights from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2003;41(6 Suppl A):325A.
  54. Goodman SG, Yan AT, Allegrone J, López-Sendón J, Granger CB, Gore JM, Budaj A, Georgescu AA, Hassan Q, Luchansky J, Van de Werf F, for the GRACE ECG Substudy Investigators. Disagreement in the interpretation of the admission electrocardiogram in acute coronary syndromes and association with clinical outcome: real-world insights from GRACE. J Am Coll Cardiol 2005; 45 (3 Suppl A):219A.
  55. Gore JM, Burns M, Goldberg RJ, Allegrone J, Montalescot G, Spencer FA, Smyth T, Brieger D, for the GRACE Investigators. Prehospital delay, receipt of reperfusion therapy, and hospital outcomes. Observations from the Global Registry of Acute Coronary Events. Circulation 2004;110(17 Suppl III):III-765.
  56. Gore J, Fox KAA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum Á, Huang W, Steg PhG. Increased all-cause mortality at 2 year follow-up after PCI with drug-eluting stents vs bare metal stents in acute coronary syndromes: the GRACE registry experience. Eur Heart J 2007 [hotline presentation].
  57. Gore JM, Goldberg RJ, Saperia G, Brieger D, Gurfinkel EP, Campo A, Steg PG, Allegrone J, Spencer FA, for the GRACE Investigators. Does time of day and day of the week affect the receipt of reperfusion therapy and hospital outcomes? The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2005; 45 (3 Suppl A):186A.
  58. Gore JM, Goldberg RJ, Spencer F, DiBenedetto D, Eagle KA, Steg PG, Allegrone J, Fox KAA, for the GRACE Investigators. Early use of low-molecular-weight or unfractionated heparin in patients with non-ST-segment elevation myocardial infarction and unstable angina: the GRACE experience. Eur Heart J 2004; 25(Abstr Suppl):1514.
  59. Gore JM, Marre M, Steg PhG, Brieger D, Quill A, Goodman SG, for the GRACE Investigators. Treatment and outcome of diabetic patients with an acute coronary syndrome: has there been any improvement over time? The GRACE registry. J Am Coll Cardiol 2008; 51(10 Suppl A):1012-134.
  60. Gore JM, Spencer FA, Marre M, Goldberg RJ, Klein W, Kasper RS, Budaj A, Mazurek T, Steg PhG, for the GRACE Investigators. Impact and treatment of diabetes (Type I and II) on prognosis in acute coronary syndromes – results from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2001;37(2 Suppl A):508A.
  61. Gore JM, Spencer FA, Gurfinkel EP, López-Sendón J, Anderson FA, FitzGerald G, Granger CB. Incidence of heparin-induced thrombocytopenia lower than expected in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Circulation 2006;114(18 Suppl. II):II-863.
  62. Granger C, López-Sendón J, Van de Werf F, Kline-Rogers E, Anderson FA, Johnson J, Sadiq I, Klein W, Eagle KA, for the GRACE Investigators. Applying the evidence in acute coronary syndromes: a report card from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2001;37(2 Suppl A):503A.
  63. Gulba DC, Lankes W, López-Sendón J, Lim MJ, Kline-Rogers E, Herbrandt R, Aler D, Kuznetsova P, Mehta R. Reduced risk of bleeding complications in patients with renal insufficiency and acute coronary syndromes treated with low-molecular-weight heparin: insights from GRACE. Circulation 2002;106(19 Suppl II):II-337.
  64. Gurfinkel E, Duronto E, Guerloy F, Kennelly BM, López-Sendón J, Avezum Á, Beck E, Eagle KA, Fitzgerald G, Gore JM. Utility of the Global Registry of Acute Coronary Events Risk Score in Mild or Severe Obstructive Coronary Artery Disease in Non-ST-segment Elevation Acute Coronary Syndromes. Circulation 2008.
  65. Gurfinkel EP, Klein W, Goodman SG, Avezum Á, Lopez de Sa E, Duronto E, Sadiq I, Goldberg RJ, Johnson J. ‘Nécrosette’ infarction versus traditionally defined non-ST-segment elevation myocardial infarction (NSTEMI) and in-hospital course. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2001;22(Abstr Suppl):519.
  66. Gurm HS, Steg PG, Montalescot G, Fox KAA, Gore JM, Dedrick R, Eagle KA. White elephant or useful tool? Incremental prognostic value of C-reactive protein in patients with acute coronary syndromes. The GRACE registry. Circulation 2007;116(Abstr Suppl):II_859.
  67. Jelinek M, Goodman SG, López-Sendón J, Gurfinkel E, White K, Brieger D, on behalf of the GRACE Investigators. The impact of the new definition of acute myocardial infarction on patients discharged with unstable angina pectoris. Six-month outcomes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24(Abstr Suppl):723.
  68. Jolly S, Goodman SG, Shenkman H, Brieger D, Fox KAA, Yan AT, Allegrone J, Eagle KA, for the GRACE Investigators. Quantitative troponin predicts cardiogenic shock, sustained ventricular arrthymias, cardiac arrest and reinfarction in non-ST-elevation acute coronary syndromes. The GRACE Registry. Eur Heart J 2006;27(Abstract Suppl):223.
  69. Klein W, Kraxner W, Hödls R, Steg PhG, Budaj A, Gulba D, Van de Werf F, Sadiq I, White K, Fox KAA, for the GRACE Investigators. Improved survival and reduced bleeding with low-molecular-weight heparin across all acute coronary syndromes subsets: findings from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2002;39(5 Suppl A):444A.
  70. Kerner K, Feldman L, FitzGerald G, Van de Werf F, López-Sendón J, Gore JM, Anderson FA, Avezum Á, Steg PG, for the GRACE Investigators. Impact of Revascularization on Outcomes in Patients with Non?ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2008;29(Abstr Suppl), 514.
  71. LaBounty T, Gurm HS, Goodman SG, Montalescot G, López-Sendón J, Quill AL, Eagle KA, for the GRACE Investigators Predictors and implications of Q-waves in ST-elevation myocardial infarction: A contemporary perspective from the Global Registry of Acute Coronary Events. Circulation 2007;116(Abstr Suppl):II_526.
  72. Lankes W, Gulba D, Johnson J, Forth J, on behalf of the GRACE Investigators. Acute coronary syndromes in the elderly: insights from the GRACE registry. Eur Heart J 2002;23(Abstr Suppl):502.
  73. Lankes W, Himbert D, Littwitz H, White K, Gulba D, on behalf of the GRACE Investigators. Impact of smoking status on outcomes in acute coronary syndromes: the ex-smokers’ paradox. Eur Heart J 2002;23(Abstr Suppl):361.
  74. Lim MJ, Eagle KA, Gore JM, Goldberg RJ, Mehta RH, Granger CB, Dabbous OH, Spencer FA, on behalf of the GRACE Investigators. Treating patients with acute coronary syndromes with aggressive anti-platelet agents in the GRACE registry: no observed decrease in in-hospital mortality but increased bleeding complications. Eur Heart J 2003;24(Abstr Suppl):547.
  75. Lim MJ, Spencer FA, Gore JM, Dabbous OH, Kline-Rogers EM, Goldberg RJ, DiBenedetto D, Eagle KA, Mehta RH, on behalf of the GRACE Investigators. Six-month mortality rates are lower in patients with an acute coronary syndrome treated with the combination of clopidogrel and a statin than in patients treated with either therapy alone. An analysis from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2003;41(6 Suppl A):361A.
  76. López-Sendón J, Dabbous OH, Lopez de Sa E, Gore JM, Brieger D, Van de Werf F, Gurfinkel EP, Fox KAA, for the GRACE Investigators. Bleeding events with lytics and thienopyridines in patients with ST-segment elevation myocardial infarction: insights from a large clinical practice registry. Eur Heart J 2004;25(Abstr Suppl):2056.
  77. López-Sendón J, Goodman SG, Steg PG, Brieger D, Eagle KA, Granger CB, Gurfinkel EP, Dedrick R, Gore JM. Heparin therapy during fibrinolysis in ST-segment elevation myocardial infarction: registry data support clinical trial results. Circulation 2006;114(18 Suppl. II):II-863.
  78. López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, FitzGerald G, Granger CB, for the GRACE Investigators. Factors related to heart rupture in acute coronary syndromes. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2008; 51(10 Suppl A):1012-140.
  79. Lu SZ, Chen YD, Ge JB, Wu SR, Yan XW, Li WM, Huang W, Anderson Jr., FA, for the GRACE Investigators. How does in-hospital management of acute coronary syndromes compare in Chinese versus European tertiary hospitals? Findings from the Global Registry of Acute Coronary Events. Eur Heart J 2005;26(Abstract Suppl.):721.
  80. Medi C, Montalescot G, Budaj A, Fox KAA, López-Sendón J, FitzGerald G, Brieger B, for the GRACE Investigators. Revascularization associated with mixed outcomes in acute coronary syndrome patients with chronic kidney disease. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2007; 49(Suppl I):292A
  81. Mehta RH, Dabbous O, Kuznetsova P, Kline-Rogers E, Gore J, Goldberg R, Eagle KA, on behalf of the GRACE Investigators. Predictors of new onset atrial fibrillation in patients presenting with acute coronary syndromes and their in-hospital outcomes. Eur Heart J 2002;23(Abstr Suppl):584.
  82. Mehta RH, Eagle KA, Kline-Rogers E, Goldberg RJ, Gore JM, Avezum Á, Fox KA, Spencer F, Johnson J, Sadiq I, on behalf of the GRACE Investigators. Is primary angioplasty better than thrombolytic therapy in elderly patients with acute myocardial infarction? An insight from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2002;39(5 Suppl A):174A.
  83. Mehta RH, Van De Werf F, Avezum Á, Agnelli G, Eagle KA, Goldberg RJ, Dabbous OH, Granger CB. Despite geographical heterogeneity in baseline use, guideline-directed treatments for acute coronary syndromes improve in all regions from 1999 to 2003. The Global Registry of Acute Coronary Events. Circulation 2005;112(Suppl):II-794.
  84. Montalescot G, Brieger D, Eagle KA, Anderson FA, FitzGerald G, Lee MS, Steg PhG, Avezum Á, Goodman SG, Gore JM, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Unprotected Left Main Revascularization in Patients With Acute Coronary Syndromes. Eur Heart J 2009 (in press) hotline.
  85. Montalescot G, Avezum Á, Brieger D, Kennelly BM, Mazurek T, Gulba D, Van de Werf F, Gore JM, White K, Spencer F. Stenting and glycoprotein IIb/IIIa inhibition in angioplasty for acute myocardial infarction in the global registry of acute coronary events (GRACE). Eur Heart J 2001;22(Abstr Suppl):359.
  86. Montalescot G, Dabbous O, Lim M, Sadiq I, Gowda N, Mehta R. Expeditive catheterization and outcomes in non-ST elevation ACS: Results from the Global Registry of Acute Coronary Events. Circulation 2002;106(19 Suppl II):II-446.
  87. Motivala A, Van De Werf F, López-Sendón J, Budaj A, Gore JM, Anderson FA, Eagle KA. Management and outcomes of acute coronary syndromes in patients with or without a prior stroke. The Global Registry of Acute Coronary Events. Eur Heart J 2007;28(Abstr Suppl):763-764.
  88. Moscucci M, Fox KAA, Cannon CP, Klein W, White K, López-Sendón J, Montalescot G, Goldberg RJ, for the GRACE Investigators. Preventing major bleeding in acute coronary syndromes: lessons learned from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 2001;37(2 Suppl A):511A.
  89. Mukherjee D, Eagle KA, Kline-Rogers E, Agnelli G, Budaj A, Avezum Á, Allegrone J, Steg PG. Acute Coronary Syndrome as a Manifestation of Global Atherosclerosis – Impact of Prior Peripheral Arterial Disease and Stroke on Clinical Outcomes. The Global Registry of Acute Coronary Events. Eur Heart J 2005;26(Abstract Suppl.):697.
  90. Mukherjee D, Froehlich JB, Kline-Rogers E, Avezum Á, López-Sendón J, Johnson J, Mehta RH. Prognostic implications of peripheral vascular disease in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Circulation 2002;106(19 Suppl II):II-678.
  91. Mukherjee D, Kline-Rogers E, Eagle KA, Feldman LJ, Juliard J-M, Allegrone J, Steg PhG, for the GRACE Investigators. Acute coronary syndrome as a manifestation of global atherosclerosis: impact of combination evidence-based therapy on mortality and morbidity in acute coronary syndrome. The Global Registry of Acute Coronary Events. Eur Heart J 2006;27(Abstract Suppl):224.
  92. Nallamothu BK, Fox KAA, Kennelly BM, Van de Werf F, Gore JM, Steg PhG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA, for the GRACE Investigators. Is the relationship of time delay in reperfusion and mortality steeper for fibrinolysis than for primary percutaneous coronary intervention? The Global Registry of Acute Coronary Events. Circulation 2005;112(Suppl):II-793.
  93. Nguyen M, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, for the GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the global registry of acute coronary events: is it safe and effective to use just one antiplatelet agent? J Am Coll Cardiol 2006; 47(4):252A.
  94. Oliveira GB, Avezum Á, Anderson FA, Dabbous OH, Budaj A, Goldberg RJ, Brieger D, Fox KAA, Granger CB. Evidence-based risk stratification is not optimally used to target proven therapies in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;110(17 Suppl III):III-659.
  95. Oliveira G, Granger CB, Van De Werf F, Montalescot G, Fox KAA, Gulba D, Allegrone J, Avezum Á, for the GRACE Investigators. Patients with acute ST-elevation myocardial infarction and prehospital delay to presentation >12 hours: high risk of worse outcomes and selective use of reperfusion therapies. The GRACE Registry. Eur Heart J 2006;27(Abstract Suppl):912.
  96. Petrina M, Goodman SG, López-Sendón J, Steg PG, Fox KAA, Stiles M, Quill A, Eagle KA, for the GRACE Investigators. The prognostic value of 12-lead ecg in patients presenting with acute coronary syndrome (ACS). J Am Coll Cardiol 2007;49(Suppl I):187A
  97. Rossi R, Agnelli G, Spencer F, Gore J, Goldberg R, Fox KAA, Moscucci M, Sullivan C, White K, Gurfinkel E, for the GRACE Investigators. Patterns of prior antiplatelet therapy and impact on hospital outcomes in patients with acute coronary syndromes (ACS). Results from the Global Registry of Acute Coronary Events (GRACE). Thromb Haemost 2001;86(Suppl 1):P1570.
  98. Saab F, Steg PG, Avezum Á, López-Sendón J, Anderson FA, Huang W, Eagle KA. Can an elderly woman’s heart be too strong? Increased mortality with high vs. normal ejection fraction after an acute coronary syndrome. The Global Registry of Acute Coronary Events. Circulation 2006;114 (18 Suppl. II):II-513.
  99. Sadiq I, Dauerman HL, Goldberg RJ, Klein W, Brieger D, Steg PhG, Montalescot G, López-Sendón J, Budaj A, Gore JM, for the GRACE Investigators. Approach after thrombolytic therapy – invasive versus conservative management – Global Registry of Acute Coronary Events. J Am Coll Cardiol 2002;39(5 Suppl A):303A.
  100. Sadiq I, Eagle KA, Agnelli G, Steg PhG, Sullivan CM, Anderson FA Jr. Role of glycoprotein IIb/IIIa antagonists in patients with acute coronary syndromes: comparison of clinical trial data with the global registry of acute coronary events (GRACE). Eur Heart J 2001;22(Abstr Suppl):519.
  101. Scheuble A, Emery M, López-Sendón J, Lopez de Sa E, Fondard O, Dabbous OH, Eagle KA, Anderson FA, Steg PG. Patterns of early use of intravenous and oral beta-blockers in ST-segment elevation myocardial infarction in the reperfusion era. The Global Registry of Acute Coronary Events. Eur Heart J 2005;26(Abstract Suppl.):159.
  102. Spencer F, Gore JM, Goldberg RJ, Fox KAA, Moscucci M, Sullivan CM, White K, Gurfinkel E, for the GRACE Investigators. Patterns in prior antiplatelet therapy and impact on outcome in patients with ACS. Results from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2001;37(2 Suppl A):507A.
  103. Spencer FA, Gore JM, Oliveira G, Montalescot G, Fox KAA, Goodman SG, Malone S, Granger CB, for the GRACE Investigators. Determinants of delay in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. The Global Registry of Acute Coronary Events. Eur Heart J 2005;26(Abstract Suppl.):621.
  104. Steg PhG, for the GRACE Investigators. The spectrum of acute coronary syndromes: management and outcomes. Insights from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2000;21(Abstr Suppl):369.
  105. Steg PhG, Budaj A, Brieger D, Sullivan C. Use of fibrinolytic and antiplatelet therapies in patients with acute coronary syndromes (ACS). Insights from the Global Registry of Acute Coronary Events (GRACE). Thromb Haemost 2001;86(Suppl 1):P1572.
  106. Steg PG, Cottin Y, Montalescot G, Van de Werf F, Gulba DC, Fox KAA, Mehta RH, Tchetche D, Dedrick R, Granger CB. Patients on chronic warfarin therapy who present with an acute coronary syndrome are high risk and receive delayed and inadequate treatment. Circulation 2006;114 (18 Suppl. II):II-860.
  107. Steg PhG, Dabbous O, Cohen-Solal A, Aument M-C, Cannon CP, López-Sendón J, Budaj A, Klein W, for the GRACE Investigators. Determinants and outcomes of congestive heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2002;39(5 Suppl A):154A.
  108. Steg PhG, Dabbous OH, López-Sendón J, Anderson Jr, FA, Gore JM, Fox KAA, for the GRACE Investigators. 'Leading and lagging' hospitals: can processes of care be used to rank hospitals? Eur Heart J 2004;25(Abstr Suppl):2486.
  109. Steg PhG, Feldman LJ, Brami M, Vahanian A, Eagle KA, López-Sendón J, Dabbous O, Goodman SG, on behalf of the GRACE investigators. Recurrent ischaemia in acute coronary syndromes: differential impact of electrocardiogram changes on outcomes. Eur Heart J 2002;23(Abstr Suppl):588.
  110. Steg PG, López-Sendón J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA Jr, Himbert D, Allegrone J, Van de Werf F, for the GRACE Investigators. Comparison of patients with ST-segment elevation myocardial infarction enrolled in fibrinolytic drug trials with trial-eligible and trial-ineligible patients. Findings from the Global Registry of Acute Coronary Events. Circulation 2004;110(17 Suppl III):III-783.
  111. Steg PG, Van de Werf F, López-Sendón J, Gore JM, Dabbous OH, Feldman L, Anderson FA, Avezum Á, for the GRACE Investigators. Failure to use percutaneous coronary intervention in patients with an acute coronary syndrome and congestive heart failure. The Global Registry of Acute Coronary Events. J Am Coll Cardiol 2006;47(4):86A.
  112. Stiles MK, Dabbous OH, Fox KAA, for the GRACE Investigators. Bleeding events with and without thienopyridines in patients with unstable angina or non-ST-segment elevation myocardial infarction. Insights from the Global Registry of Acute Coronary Events. Eur Heart J 2004;25(Abstr Suppl):1516.
  113. Stiles MK, Dabbous OH, Fox KAA, for the GRACE Investigators. Bleeding events with and without thienopyridines in patients with unstable angina or non-ST-segment elevation myocardial infarction. The Global Registry of Acute Coronary Events. J Thromb Haemost 2005; 3(1):P1693.
  114. Tamirisa K, Gulba DC, Kim C, Klutmann M, Tillmans C, White K, Eagle KA, the GRACE Investigators. Influence of body mass index on acute coronary syndrome outcomes: lessons from the Global Registry of Acute Coronary Events. J Am Coll Cardiol 2004;43(5 Suppl A):288A.
  115. Van de Werf F, Avezum Á, Goodman S, Budaj A, Brieger D, Gore J, Cannon C, Kennelly B, White K, Gulba D. Interventional procedures and in-hospital outcomes in patients with acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2001;22(Abstr Suppl):617.
  116. Van de Werf F, Brieger D, Avezum A, Fox KAA, Kennelly BM, Montalescot G, Eagle KA, Goodman SG, Dedrick R, Gore JM. Impact of availability of catheterization facilities on clinical outcomes in acute coronary syndromes. The GRACE registry. Eur Heart J 2008;29(Abstr Suppl), 67.
  117. Vedre A, Gurm HS, Froehlich JB, Kline-Rogers E, Montalescot G, Gore JM, Brieger D, Dedrick R, Eagle KA, for the GRACE Investigators. Impact of chronic statin therapy on arrhythmic events in patients with acute coronary syndromes: Insights from the GRACE registry. Circulation 2007;116(Abstr Suppl):II_858.
  118. Wang T, Goodman SG, Flather MD, Gurfinkel EP, Quill AL, Menon V. No impact of drug-eluting stents on rates of in-hospital coronary artery bypass surgery following non-ST-segment elevation myocardial infarction. The GRACE registry. Eur Heart J 2007;28(Abstr Suppl):735.
  119. Yan AT, Goodman SG, Kennelly BM, Anderson Jr., FA, Allegrone J, Steg PhG, for the GRACE Investigators. Prevalence and prognostic significance of ST elevation in aVR: insights from the Global Registry of Acute Coronary Events Electrocardiographic Substudy. Eur Heart J 2005;26(Abstr Suppl):282.
GRACE is supported by a grant from Sanofi
For general questions and information: GRACE@umassmed.edu • 508.856.0081
Copyright 1998-2018 Center for Outcomes Research, University of Massachusetts Medical School